1. Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma
   Alphonse E Sirica, 2008, World Journal of Gastroenterology CrossRef
2. Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma
   Massimiliano Cadamuro et al, 2022, Journal of Personalized Medicine CrossRef
3. Antisense to Cyclin D1 Inhibits VEGF-Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization
   Richard G. Pestell et al, 2006, Clinical Cancer Research CrossRef
4. Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
   Valeria Simone et al, 2017, International Journal of Molecular Sciences CrossRef
5. Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer
   Yue Wang et al, 2021, Frontiers in Oncology CrossRef
6. Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy
   Chantal Dreyer, 2015, World Journal of Hepatology CrossRef
7. Angiogenesis: the Yin and Yang in intrahepatic cholangiocarcinoma
   Adriana Romanzi et al, 2023, Hepatoma Research CrossRef
8. Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
   Maria Maddalena Simile et al, 2019, Medicina CrossRef
9. Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer
   Xiao-Hong Liu et al, 2008, World Journal of Gastroenterology CrossRef
10. Exploring the Mechanism of Scutellaria baicalensis Georgi Efficacy against Oral Squamous Cell Carcinoma Based on Network Pharmacology and Molecular Docking Analysis
    Fanfan Hou et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
11. Role of the Angiogenic Factors in Cholangiocarcinoma
    Romina Mancinelli et al, 2019, Applied Sciences CrossRef